Hugo_Symbol Entrez_Gene_Id Center NCBI_Build Chromosome Start_position End_position Strand Variant_Classification Variant_Type Reference_Allele Tumor_Seq_Allele1 Tumor_Seq_Allele2 dbSNP_RS dbSNP_Val_Status Tumor_Sample_Barcode Matched_Norm_Sample_Barcode Match_Norm_Seq_Allele1 Match_Norm_Seq_Allele2 Tumor_Validation_Allele1 Tumor_Validation_Allele2 Match_Norm_Validation_Allele1 Match_Norm_Validation_Allele2 Verification_Status Validation_Status Mutation_Status Sequencing_Phase Sequence_Source Validation_Method Score BAM_file Sequencer Tumor_Sample_UUID Matched_Norm_Sample_UUID Genome_Change Annotation_Transcript Transcript_Strand Transcript_Exon Transcript_Position cDNA_Change Codon_Change Protein_Change Other_Transcripts Refseq_mRNA_Id Refseq_prot_Id SwissProt_acc_Id SwissProt_entry_Id Description UniProt_AApos UniProt_Region UniProt_Site UniProt_Natural_Variations UniProt_Experimental_Info GO_Biological_Process GO_Cellular_Component GO_Molecular_Function COSMIC_overlapping_mutations COSMIC_fusion_genes COSMIC_tissue_types_affected COSMIC_total_alterations_in_gene Tumorscape_Amplification_Peaks Tumorscape_Deletion_Peaks TCGAscape_Amplification_Peaks TCGAscape_Deletion_Peaks DrugBank ref_context gc_content CCLE_ONCOMAP_overlapping_mutations CCLE_ONCOMAP_total_mutations_in_gene CGC_Mutation_Type CGC_Translocation_Partner CGC_Tumor_Types_Somatic CGC_Tumor_Types_Germline CGC_Other_Diseases DNARepairGenes_Role FamilialCancerDatabase_Syndromes MUTSIG_Published_Results OREGANNO_ID OREGANNO_Values t_alt_count t_ref_count validation_alt_allele validation_method validation_status validation_tumor_sample pox qox pox_cutoff isArtifactMode oxoGCut TP53 7157 broad.mit.edu 37 17 7579363 7579363 + Silent SNP A A C TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr17:7579363A>C ENST00000420246.2 - 4 456 c.324T>G c.(322-324)ggT>ggG p.G108G TP53_ENST00000269305.4_Silent_p.G108G|TP53_ENST00000359597.4_Silent_p.G108G|TP53_ENST00000413465.2_Silent_p.G108G|TP53_ENST00000445888.2_Silent_p.G108G|TP53_ENST00000455263.2_Silent_p.G108G NM_001126114.2|NM_001276696.1 NP_001119586.1|NP_001263625.1 P04637 P53_HUMAN tumor protein p53 108 Interaction with HIPK1 (By similarity).|Interaction with WWOX. G -> D (in a sporadic cancer; somatic mutation).|G -> S (in sporadic cancers; somatic mutation). activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding p.0?(8)|p.Q100fs*37(3)|p.G59fs*23(3)|p.F109fs*16(3)|p.G108_F109delGF(2)|p.G108del(2)|p.V73fs*9(1)|p.G105_T125del21(1)|p.?_?ins?(1)|p.Y107fs*44(1)|p.W91fs*13(1)|p.Y103_G112>C(1)|p.P13fs*18(1)|p.S33fs*23(1)|p.G108G(1)|p.Y107fs*38(1)|p.Y103_L111>L(1) NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79) 24185 all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081) GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174) CCAGACGGAAACCGTAGCTGC 0.617000 111 """Mis, N, F""" """breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types""" """breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types""" Other conserved DNA damage response genes Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019) 23 37 0 0 0.654019 0 0 UBR5 51366 broad.mit.edu 37 8 103359284 103359284 + Silent SNP T T C TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr8:103359284T>C ENST00000520539.1 - 6 1029 c.423A>G c.(421-423)ggA>ggG p.G141G UBR5_ENST00000220959.4_Silent_p.G141G|UBR5_ENST00000521922.1_Silent_p.G141G NM_015902.5 NP_056986.2 O95071 UBR5_HUMAN ubiquitin protein ligase E3 component n-recognin 5 141 cell proliferation|positive regulation of canonical Wnt receptor signaling pathway|positive regulation of catenin import into nucleus|positive regulation of protein import into nucleus, translocation|progesterone receptor signaling pathway|protein polyubiquitination|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|response to DNA damage stimulus nucleus|soluble fraction protein binding|RNA binding|ubiquitin-ubiquitin ligase activity|zinc ion binding NS(1)|breast(13)|central_nervous_system(1)|cervix(1)|endometrium(7)|kidney(8)|large_intestine(19)|liver(1)|lung(51)|ovary(6)|pancreas(1)|prostate(5)|skin(6)|upper_aerodigestive_tract(2)|urinary_tract(2) 124 all_cancers(14;8e-07)|all_epithelial(15;2.18e-08)|Lung NSC(17;2.55e-05)|all_lung(17;8.85e-05) OV - Ovarian serous cystadenocarcinoma(57;0.000442) CAGAGGATCCTCCACCACTTC 0.483000 72 87 0 0 0.870114 0 0 COQ10B 80219 broad.mit.edu 37 2 198338608 198338608 + Missense_Mutation SNP T T C TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr2:198338608T>C ENST00000263960.2 + 5 815 c.677T>C c.(676-678)aTa>aCa p.I226T COQ10B_ENST00000409010.1_Missense_Mutation_p.I198T|COQ10B_ENST00000545340.1_Missense_Mutation_p.I183T|COQ10B_ENST00000409398.1_Missense_Mutation_p.I176T NM_025147.3 NP_079423.1 Q9H8M1 CQ10B_HUMAN coenzyme Q10 homolog B (S. cerevisiae) 226 mitochondrial inner membrane endometrium(1)|large_intestine(2)|lung(3) 6 Epithelial(96;0.231)|OV - Ovarian serous cystadenocarcinoma(117;0.246) GAAACAAATATACCTCGGGAG 0.413000 31 42 0 0 0.804634 0 0 SEMG1 6406 broad.mit.edu 37 20 43836817 43836817 + Silent SNP A A G rs17850164 TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr20:43836817A>G ENST00000372781.3 + 2 936 c.879A>G c.(877-879)acA>acG p.T293T SEMG1_ENST00000244069.6_Intron NM_003007.3 NP_002998.1 semenogelin I p.T293T(2) cervix(1)|endometrium(2)|kidney(3)|large_intestine(3)|liver(1)|lung(12)|prostate(1)|skin(6)|stomach(2)|urinary_tract(1) 32 Myeloproliferative disorder(115;0.0122) CTTCAAGTACAGAAGAAAGAC 0.383000 3 86 0 0 0.115264 0 0 TP53 7157 broad.mit.edu 37 17 7578502 7578502 + Missense_Mutation SNP A A C TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr17:7578502A>C ENST00000420246.2 - 5 560 c.428T>G c.(427-429)gTg>gGg p.V143G TP53_ENST00000269305.4_Missense_Mutation_p.V143G|TP53_ENST00000359597.4_Missense_Mutation_p.V143G|TP53_ENST00000413465.2_Missense_Mutation_p.V143G|TP53_ENST00000445888.2_Missense_Mutation_p.V143G|TP53_ENST00000455263.2_Missense_Mutation_p.V143G NM_001126114.2|NM_001276696.1 NP_001119586.1|NP_001263625.1 P04637 P53_HUMAN tumor protein p53 143 Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42. V -> A (in sporadic cancers; somatic mutation; strong DNA binding ability at 32.5 degrees Celsius; strong reduction of transcriptional activity at 37.5 degrees Celsius).|V -> E (in sporadic cancers; somatic mutation).|V -> G (in sporadic cancers; somatic mutation).|V -> L (in sporadic cancers; somatic mutation).|V -> M (in sporadic cancers; somatic mutation). activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding p.V143A(18)|p.0?(8)|p.V143E(5)|p.V11A(2)|p.V50A(2)|p.L137_W146del10(1)|p.P142_Q144delPVQ(1)|p.K139fs*4(1)|p.A138_V143delAKTCPV(1)|p.V143G(1)|p.V143_S149del(1)|p.C141fs*5(1) NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79) 24185 all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081) GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174) CCACAGCTGCACAGGGCAGGT 0.587000 111 """Mis, N, F""" """breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types""" """breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types""" Other conserved DNA damage response genes Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019) 21 31 0 0 0.654019 0 0 ATP8A2 51761 broad.mit.edu 37 13 26125550 26125550 + Silent SNP C C A TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr13:26125550C>A ENST00000381655.2 + 11 1108 c.966C>A c.(964-966)ggC>ggA p.G322G ATP8A2_ENST00000255283.8_Silent_p.G282G NM_016529.4 NP_057613.4 Q9NTI2 AT8A2_HUMAN ATPase, aminophospholipid transporter, class I, type 8A, member 2 282 ATP biosynthetic process|negative regulation of cell proliferation integral to membrane ATP binding|ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism|magnesium ion binding|phospholipid-translocating ATPase activity breast(1)|endometrium(7)|haematopoietic_and_lymphoid_tissue(2)|kidney(5)|large_intestine(17)|lung(31)|ovary(4)|skin(3)|stomach(1)|urinary_tract(1) 72 Breast(139;0.0201)|Lung SC(185;0.0225) all cancers(112;0.043)|OV - Ovarian serous cystadenocarcinoma(117;0.0748)|Epithelial(112;0.079) TGTTGTTTGGCATCCTCTTGG 0.483000 3 45 0.115264 0.117616 0.115264 1 0 DLC1 10395 broad.mit.edu 37 8 12952306 12952306 + Missense_Mutation SNP G G A TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr8:12952306G>A ENST00000276297.4 - 12 3897 c.3488C>T c.(3487-3489)aCg>aTg p.T1163M DLC1_ENST00000510318.1_5'UTR|DLC1_ENST00000512044.2_Missense_Mutation_p.T760M|DLC1_ENST00000358919.2_Missense_Mutation_p.T726M|DLC1_ENST00000520226.1_Missense_Mutation_p.T652M NM_182643.2 NP_872584.2 Q96QB1 RHG07_HUMAN deleted in liver cancer 1 1163 Rho-GAP. actin cytoskeleton organization|activation of caspase activity|focal adhesion assembly|forebrain development|heart morphogenesis|hindbrain morphogenesis|induction of apoptosis|negative regulation of cell migration|negative regulation of cell proliferation|negative regulation of Rho protein signal transduction|negative regulation of stress fiber assembly|neural tube closure|positive regulation of protein dephosphorylation|regulation of cell shape|small GTPase mediated signal transduction caveola|cytosol|focal adhesion|nucleus Rho GTPase activator activity|SH2 domain binding p.T1163M(1) NS(2)|breast(2)|cervix(1)|endometrium(7)|haematopoietic_and_lymphoid_tissue(2)|kidney(5)|large_intestine(39)|lung(32)|ovary(4)|pancreas(2)|prostate(4)|skin(2)|stomach(2)|upper_aerodigestive_tract(5)|urinary_tract(1) 110 GAGTTTGTTCGTCATTAGTGG 0.448000 31 34 0 0 0.788014 0 0 ZNF761 388561 broad.mit.edu 37 19 53945909 53945909 + RNA SNP T T C rs28727441 by1000genomes TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr19:53945909T>C ENST00000454407.1 + 0 55 TPM3P9_ENST00000424846.3_RNA Q86XN6 ZN761_HUMAN zinc finger protein 761 regulation of transcription, DNA-dependent|transcription, DNA-dependent nucleus DNA binding|zinc ion binding endometrium(1)|kidney(2)|large_intestine(5)|lung(13)|ovary(1)|prostate(2)|skin(4)|stomach(1)|upper_aerodigestive_tract(1) 30 GBM - Glioblastoma multiforme(134;0.00786) ACCCTGACTCTGCCTGAGGCC 0.562000 3 38 0 0 0.184627 0 0 C22orf29 79680 broad.mit.edu 37 22 19839287 19839287 + Missense_Mutation SNP G G C TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr22:19839287G>C ENST00000405640.1 - 2 1166 c.498C>G c.(496-498)gaC>gaG p.D166E GNB1L_ENST00000405009.1_Intron|C22orf29_ENST00000484072.1_Intron|GNB1L_ENST00000403325.1_Intron|GNB1L_ENST00000329517.6_Intron|GNB1L_ENST00000460402.1_Intron|C22orf29_ENST00000328554.4_Missense_Mutation_p.D166E|C22orf29_ENST00000407472.1_Missense_Mutation_p.D166E Q7L3V2 CV029_HUMAN chromosome 22 open reading frame 29 166 NS(1)|large_intestine(1)|lung(3)|prostate(1)|urinary_tract(1) 7 Colorectal(54;0.0993) GCTCGTAATCGTCAGGCAGGG 0.597000 4 98 0 0 0.217242 0 0 MST1L 0 broad.mit.edu 37 1 17084732 17084732 + RNA SNP G G A TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr1:17084732G>A ENST00000455405.2 - 0 284 GCACTGCCGGGCAGTCAGTAT 0.577000 3 4 0 0 0.115264 0 0 DNAH8 1769 broad.mit.edu 37 6 38893890 38893890 + Silent SNP T T A TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr6:38893890T>A ENST00000359357.3 + 72 10625 c.10371T>A c.(10369-10371)atT>atA p.I3457I RP1-207H1.3_ENST00000418399.1_RNA|DNAH8_ENST00000449981.2_Silent_p.I3674I|DNAH8_ENST00000441566.1_Silent_p.I3421I|RP1-207H1.3_ENST00000416948.1_RNA dynein, axonemal, heavy chain 8 NS(7)|breast(9)|central_nervous_system(4)|cervix(1)|endometrium(12)|haematopoietic_and_lymphoid_tissue(3)|kidney(16)|large_intestine(44)|liver(4)|lung(101)|ovary(7)|pancreas(2)|prostate(8)|skin(28)|stomach(4)|upper_aerodigestive_tract(6)|urinary_tract(4) 260 AGAATGGCATTATTGTGACAA 0.408000 15 116 0 0 0.500413 0 0 TBC1D9 23158 broad.mit.edu 37 4 141543729 141543729 + Missense_Mutation SNP G G A TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr4:141543729G>A ENST00000442267.2 - 21 3495 c.3421C>T c.(3421-3423)Cgg>Tgg p.R1141W NM_015130.2 NP_055945.2 Q6ZT07 TBCD9_HUMAN TBC1 domain family, member 9 (with GRAM domain) 1141 intracellular calcium ion binding|Rab GTPase activator activity endometrium(3)|kidney(2)|large_intestine(3)|lung(18)|ovary(1)|prostate(3)|upper_aerodigestive_tract(1) 31 all_hematologic(180;0.162) Medulloblastoma(177;0.00498) CCGTTGTCCCGGGGCGAGGAG 0.637000 20 79 0 0 0.608945 0 0 DLGAP1 9229 broad.mit.edu 37 18 3879577 3879577 + Silent SNP G G A TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr18:3879577G>A ENST00000315677.3 - 4 1087 c.492C>T c.(490-492)aaC>aaT p.N164N DLGAP1_ENST00000584874.1_Silent_p.N164N|DLGAP1_ENST00000515196.2_Silent_p.N164N|DLGAP1-AS3_ENST00000577649.1_RNA|DLGAP1_ENST00000581527.1_Silent_p.N164N NM_004746.3 NP_004737.2 O14490 DLGP1_HUMAN discs, large (Drosophila) homolog-associated protein 1 164 synaptic transmission cell junction|postsynaptic density|postsynaptic membrane breast(2)|endometrium(3)|kidney(1)|large_intestine(5)|lung(31)|ovary(2)|pancreas(1)|prostate(1)|skin(3)|upper_aerodigestive_tract(6)|urinary_tract(1) 56 Colorectal(8;0.0257) CCTTGCCCCCGTTGACGCTGC 0.711000 33 84 0 0 0.769981 0 0 TP53 7157 broad.mit.edu 37 17 7579362 7579362 + Missense_Mutation SNP A A C TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr17:7579362A>C ENST00000420246.2 - 4 457 c.325T>G c.(325-327)Ttc>Gtc p.F109V TP53_ENST00000269305.4_Missense_Mutation_p.F109V|TP53_ENST00000359597.4_Missense_Mutation_p.F109V|TP53_ENST00000413465.2_Missense_Mutation_p.F109V|TP53_ENST00000445888.2_Missense_Mutation_p.F109V|TP53_ENST00000455263.2_Missense_Mutation_p.F109V NM_001126114.2|NM_001276696.1 NP_001119586.1|NP_001263625.1 P04637 P53_HUMAN tumor protein p53 109 Interaction with HIPK1 (By similarity).|Interaction with WWOX. F -> C (in sporadic cancers; somatic mutation).|F -> L (in a sporadic cancer; somatic mutation).|F -> S (in sporadic cancers; somatic mutation). activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding p.0?(8)|p.Q100fs*37(3)|p.G59fs*23(3)|p.F109fs*16(3)|p.G108_F109delGF(2)|p.F109_R110delFR(2)|p.V73fs*9(1)|p.G105_T125del21(1)|p.Y107fs*44(1)|p.W91fs*13(1)|p.Y103_G112>C(1)|p.P13fs*18(1)|p.S33fs*23(1)|p.Y107fs*38(1)|p.F109V(1)|p.Y103_L111>L(1) NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79) 24185 all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081) GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174) CCCAGACGGAAACCGTAGCTG 0.612000 111 """Mis, N, F""" """breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types""" """breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types""" Other conserved DNA damage response genes Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019) 23 38 0 0 0.654019 0 0 KIAA1324L 222223 broad.mit.edu 37 7 86542420 86542420 + Missense_Mutation SNP G G C TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr7:86542420G>C ENST00000450689.2 - 14 2017 c.1832C>G c.(1831-1833)tCt>tGt p.S611C KIAA1324L_ENST00000444627.1_Intron|KIAA1324L_ENST00000416314.1_Missense_Mutation_p.S444C|KIAA1324L_ENST00000490995.1_5'UTR|KIAA1324L_ENST00000297222.6_Missense_Mutation_p.S371C NM_001142749.2 NP_001136221.1 A8MWY0 K132L_HUMAN KIAA1324-like 611 integral to membrane breast(2)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(11)|lung(14)|ovary(6)|prostate(3)|skin(2)|upper_aerodigestive_tract(1) 44 Esophageal squamous(14;0.0058) CGACTGTTCAGAACCGAGGGC 0.517000 11 53 0 0 0.387290 0 0 PRDM2 7799 broad.mit.edu 37 1 14143064 14143064 + Splice_Site SNP A A G TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr1:14143064A>G ENST00000376048.5 + 7 780 c.655_splice c.e7+1 p.T218_splice PRDM2_ENST00000235372.7_3'UTR|PRDM2_ENST00000503842.1_Splice_Site_p.T54_splice|PRDM2_ENST00000505823.1_Splice_Site_p.T54_splice NM_001135610.1 NP_001129082.1 Q13029 PRDM2_HUMAN PR domain containing 2, with ZNF domain 0 Golgi apparatus|nucleus DNA binding|histone-lysine N-methyltransferase activity|sequence-specific DNA binding transcription factor activity|zinc ion binding endometrium(9)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(16)|lung(20)|ovary(3)|prostate(3)|skin(1)|urinary_tract(2) 55 Ovarian(185;0.249) all_lung(284;2.56e-05)|Lung NSC(185;4.94e-05)|Renal(390;0.000147)|Breast(348;0.000162)|Colorectal(325;0.00058)|Ovarian(437;0.00965)|Hepatocellular(190;0.0245)|Myeloproliferative disorder(586;0.0255) GBM - Glioblastoma multiforme(2;0.00182) UCEC - Uterine corpus endometrioid carcinoma (279;0.00224)|Colorectal(212;3.23e-08)|BRCA - Breast invasive adenocarcinoma(304;2.16e-05)|COAD - Colon adenocarcinoma(227;2.53e-05)|Kidney(185;0.000762)|KIRC - Kidney renal clear cell carcinoma(229;0.00258)|STAD - Stomach adenocarcinoma(313;0.00446)|READ - Rectum adenocarcinoma(331;0.0276)|Lung(427;0.145) GCTCCCTGACAGGTACGAGGC 0.577000 6 27 0 0 0.248553 0 0 PDE4C 5143 broad.mit.edu 37 19 18329192 18329192 + Silent SNP G G A rs149723522 TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr19:18329192G>A ENST00000355502.3 - 14 2053 c.1182C>T c.(1180-1182)gcC>gcT p.A394A PDE4C_ENST00000594465.2_Silent_p.A394A|PDE4C_ENST00000594617.2_Silent_p.A394A|PDE4C_ENST00000447275.2_Silent_p.A288A|PDE4C_ENST00000539010.1_Silent_p.A163A|PDE4C_ENST00000262805.11_Silent_p.A362A|AC068499.10_ENST00000594805.2_RNA Q08493 PDE4C_HUMAN phosphodiesterase 4C, cAMP-specific 394 signal transduction cytosol 3',5'-cyclic-AMP phosphodiesterase activity|metal ion binding breast(2)|central_nervous_system(2)|endometrium(4)|kidney(3)|large_intestine(2)|lung(9)|ovary(2)|prostate(2)|skin(2)|stomach(2)|upper_aerodigestive_tract(1)|urinary_tract(2) 33 Dyphylline(DB00651) GGGCCACGTCGGCGGCATGTA 0.637000 42 75 0 0 0.870114 0 0 IDH1 3417 broad.mit.edu 37 2 209113112 209113112 + Missense_Mutation SNP C C T rs121913500 TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr2:209113112C>T ENST00000415913.1 - 4 776 c.395G>A c.(394-396)cGt>cAt p.R132H IDH1_ENST00000345146.2_Missense_Mutation_p.R132H|IDH1_ENST00000446179.1_Missense_Mutation_p.R132H O75874 IDHC_HUMAN isocitrate dehydrogenase 1 (NADP+), soluble 132 R -> C (in colorectal cancer and glioma samples; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha- ketoglutarate but instead alpha- ketoglutarate is converted to R(-)-2- hydroxyglutarate).|R -> G (in a glioma sample; glioblastoma multiforme; somatic mutation).|R -> H (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> L (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> S (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate). 2-oxoglutarate metabolic process|cellular lipid metabolic process|glyoxylate cycle|isocitrate metabolic process|NADPH regeneration|tricarboxylic acid cycle cytosol|peroxisomal matrix isocitrate dehydrogenase (NADP+) activity|magnesium ion binding|NAD binding|protein homodimerization activity p.R132H(2774)|p.R132L(59)|p.R132V(1)|p.G131_R132>VL(1) NS(1)|autonomic_ganglia(2)|biliary_tract(24)|bone(237)|central_nervous_system(3764)|endometrium(3)|haematopoietic_and_lymphoid_tissue(794)|kidney(2)|large_intestine(7)|lung(7)|prostate(6)|skin(5)|soft_tissue(12)|thyroid(22)|urinary_tract(1) 4887 Epithelial(149;0.0322)|LUSC - Lung squamous cell carcinoma(261;0.0711)|Lung(261;0.136) ATAAGCATGACGACCTATGAT 0.393000 Mis gliobastoma 28 48 0 0 0.750413 0 0 TEX15 56154 broad.mit.edu 37 8 30702110 30702110 + Missense_Mutation SNP T T C TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr8:30702110T>C ENST00000256246.2 - 1 4498 c.4424A>G c.(4423-4425)tAc>tGc p.Y1475C NM_031271.3 NP_112561.2 Q9BXT5 TEX15_HUMAN testis expressed 15 1475 NS(2)|breast(3)|cervix(5)|endometrium(7)|haematopoietic_and_lymphoid_tissue(1)|kidney(5)|large_intestine(38)|lung(56)|ovary(5)|pancreas(1)|prostate(2)|skin(7)|upper_aerodigestive_tract(5)|urinary_tract(1) 138 KIRC - Kidney renal clear cell carcinoma(542;0.0918)|Kidney(114;0.111) GCTTCTTTTGTAAACAGAATC 0.338000 39 42 0 0 0.812448 0 0 BAGE2 85319 broad.mit.edu 37 21 11058348 11058348 + RNA SNP C C A TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr21:11058348C>A ENST00000470054.1 - 0 324 B melanoma antigen family, member 2 Colorectal(6;3.44e-05)|COAD - Colon adenocarcinoma(6;0.00727)|READ - Rectum adenocarcinoma(6;0.0723) UCEC - Uterine corpus endometrioid carcinoma (6;0.0974)|all cancers(6;2.54e-22)|Epithelial(6;4.21e-19)|OV - Ovarian serous cystadenocarcinoma(6;1.16e-09)|BRCA - Breast invasive adenocarcinoma(6;7.72e-05)|Lung(8;0.000189)|LUSC - Lung squamous cell carcinoma(6;0.00379)|GBM - Glioblastoma multiforme(6;0.00391)|Kidney(17;0.0773)|LUAD - Lung adenocarcinoma(8;0.247) GGAGAGAAATCTCTTTATAAA 0.343000 6 156 0.00448238 0.00476849 0.307466 1 0 SHPRH 257218 broad.mit.edu 37 6 146215310 146215310 + Silent SNP T T C TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr6:146215310T>C ENST00000367503.3 - 27 5081 c.4683A>G c.(4681-4683)caA>caG p.Q1561Q SHPRH_ENST00000438092.2_Silent_p.Q1561Q|SHPRH_ENST00000275233.7_Silent_p.Q1557Q|SHPRH_ENST00000367505.2_Silent_p.Q1557Q NM_001042683.2 NP_001036148.2 Q149N8 SHPRH_HUMAN SNF2 histone linker PHD RING helicase, E3 ubiquitin protein ligase 1557 Helicase C-terminal. DNA repair|nucleosome assembly nucleosome|nucleus ATP binding|DNA binding|helicase activity|ligase activity|zinc ion binding breast(2)|central_nervous_system(2)|endometrium(8)|haematopoietic_and_lymphoid_tissue(2)|kidney(3)|large_intestine(15)|lung(33)|ovary(3)|pancreas(2)|prostate(7)|skin(1)|urinary_tract(1) 79 Ovarian(120;0.0365) OV - Ovarian serous cystadenocarcinoma(155;1.47e-07)|GBM - Glioblastoma multiforme(68;0.0124) CACGACTGATTTGTGCAAATT 0.313000 4 32 0 0 0.184627 0 0 SYNE2 23224 broad.mit.edu 37 14 64457244 64457244 + Missense_Mutation SNP C C G TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr14:64457244C>G ENST00000358025.3 + 20 2659 c.2429C>G c.(2428-2430)aCt>aGt p.T810S SYNE2_ENST00000554584.1_Missense_Mutation_p.T810S|SYNE2_ENST00000357395.3_5'UTR|SYNE2_ENST00000344113.4_Missense_Mutation_p.T810S NM_182914.2 NP_878918.2 Q8WXH0 SYNE2_HUMAN spectrin repeat containing, nuclear envelope 2 810 centrosome localization|cytoskeletal anchoring at nuclear membrane|nuclear migration along microfilament|positive regulation of cell migration cytoskeleton|filopodium membrane|focal adhesion|integral to membrane|lamellipodium membrane|mitochondrial part|nuclear outer membrane|nucleoplasm|sarcoplasmic reticulum membrane|SUN-KASH complex|Z disc actin binding|protein binding NS(5)|breast(17)|central_nervous_system(3)|cervix(8)|endometrium(17)|haematopoietic_and_lymphoid_tissue(2)|kidney(21)|large_intestine(34)|lung(75)|ovary(10)|pancreas(2)|prostate(8)|skin(8)|stomach(1)|upper_aerodigestive_tract(9)|urinary_tract(4) 224 all cancers(60;0.00153)|OV - Ovarian serous cystadenocarcinoma(108;0.00444)|BRCA - Breast invasive adenocarcinoma(234;0.0681) GTTCTCACAACTGGGCTTCAG 0.378000 28 111 0 0 0.693898 0 0 IGLV5-37 0 broad.mit.edu 37 22 22782218 22782218 + RNA SNP C C T TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr22:22782218C>T ENST00000390300.2 + 0 221 TGTACTACTACTCAGACTCAG 0.532000 24 45 0 0 0.639603 0 0 SCAI 286205 broad.mit.edu 37 9 127734030 127734030 + Missense_Mutation SNP C C T TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr9:127734030C>T ENST00000336505.5 - 16 1551 c.1493G>A c.(1492-1494)gGc>gAc p.G498D SCAI_ENST00000373549.4_Missense_Mutation_p.G521D NM_001144877.2 NP_001138349.1 Q8N9R8 SCAI_HUMAN suppressor of cancer cell invasion 498 negative regulation of cell migration|negative regulation of Rho protein signal transduction|regulation of transcription, DNA-dependent|transcription, DNA-dependent cytoplasm|integral to membrane|nucleus protein binding|transcription corepressor activity breast(2)|central_nervous_system(1)|endometrium(3)|kidney(7)|large_intestine(4)|lung(8)|ovary(2)|pancreas(1)|prostate(5)|stomach(1)|urinary_tract(1) 35 TTCCCATAGGCCTCTGCGCAT 0.428000 54 92 0 0 0.870114 0 0 COL2A1 1280 broad.mit.edu 37 12 48370602 48370602 + Missense_Mutation SNP C C T TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr12:48370602C>T ENST00000380518.3 - 48 3592 c.3428G>A c.(3427-3429)gGc>gAc p.G1143D COL2A1_ENST00000337299.6_Missense_Mutation_p.G1074D|COL2A1_ENST00000493991.1_5'UTR NM_001844.4|NM_033150.2 NP_001835.3|NP_149162.2 P02458 CO2A1_HUMAN collagen, type II, alpha 1 1143 Triple-helical region. G -> S (in ACG2). axon guidance|collagen fibril organization|embryonic skeletal joint morphogenesis|sensory perception of sound|visual perception collagen type II identical protein binding|platelet-derived growth factor binding NS(1)|breast(1)|central_nervous_system(2)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(9)|lung(25)|ovary(1)|prostate(1)|skin(7)|upper_aerodigestive_tract(2)|urinary_tract(3) 64 Acute lymphoblastic leukemia(13;0.108)|all_hematologic(14;0.214) Collagenase(DB00048) CACAGGAGGGCCGGGCAGACC 0.647000 5 9 0 0 0.184627 0 0 PDIK1L 149420 broad.mit.edu 37 1 26448766 26448766 + Missense_Mutation SNP G G A TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr1:26448766G>A ENST00000374271.4 + 4 1011 c.724G>A c.(724-726)Gct>Act p.A242T PDIK1L_ENST00000374269.1_Missense_Mutation_p.A242T NM_001243532.1|NM_001243533.1|NM_152835.4 NP_001230461.1|NP_001230462.1|NP_690048.1 Q8N165 PDK1L_HUMAN PDLIM1 interacting kinase 1 like 242 Protein kinase. nucleus ATP binding|protein serine/threonine kinase activity large_intestine(3)|lung(2)|ovary(1)|upper_aerodigestive_tract(1) 7 Colorectal(325;0.000147)|Renal(390;0.00211)|Lung NSC(340;0.00239)|all_lung(284;0.00366)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.051)|Breast(348;0.0589)|all_neural(195;0.0687) UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|OV - Ovarian serous cystadenocarcinoma(117;7.32e-26)|Colorectal(126;1.24e-08)|COAD - Colon adenocarcinoma(152;9.31e-07)|KIRC - Kidney renal clear cell carcinoma(1967;0.000735)|BRCA - Breast invasive adenocarcinoma(304;0.000973)|STAD - Stomach adenocarcinoma(196;0.00151)|GBM - Glioblastoma multiforme(114;0.015)|READ - Rectum adenocarcinoma(331;0.0649) TGACATCTTTGCTCTGGGGAT 0.423000 30 63 0 0 0.706142 0 0 CDH4 1002 broad.mit.edu 37 20 60419868 60419868 + Missense_Mutation SNP G G A TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr20:60419868G>A ENST00000360469.5 + 5 809 c.721G>A c.(721-723)Gcc>Acc p.A241T CDH4_ENST00000543233.1_Missense_Mutation_p.A167T NM_001794.3 NP_001785.2 P55283 CADH4_HUMAN cadherin 4, type 1, R-cadherin (retinal) 241 Cadherin 1. adherens junction organization|cell junction assembly calcium ion binding NS(2)|breast(2)|cervix(1)|endometrium(9)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(17)|liver(2)|lung(25)|ovary(2)|prostate(1)|skin(7)|upper_aerodigestive_tract(1)|urinary_tract(1) 74 BRCA - Breast invasive adenocarcinoma(19;2.36e-08) GGAGGAGCACGCCTCTTACCA 0.672000 10 19 0 0 0.387290 0 0 PTBP2 58155 broad.mit.edu 37 1 97278639 97278639 + Silent SNP T T A TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr1:97278639T>A ENST00000236228.6 + 13 1525 c.1443T>A c.(1441-1443)acT>acA p.T481T PTBP2_ENST00000394184.3_Silent_p.T497T|PTBP2_ENST00000426398.2_Silent_p.T481T|PTBP2_ENST00000370197.1_Silent_p.T486T|PTBP2_ENST00000541987.1_3'UTR|PTBP2_ENST00000370198.1_Silent_p.T486T|PTBP2_ENST00000482253.1_3'UTR NM_021190.2 NP_067013.1 Q9UKA9 PTBP2_HUMAN polypyrimidine tract binding protein 2 481 RRM 4. nucleotide binding central_nervous_system(1)|endometrium(3)|kidney(1)|large_intestine(5)|lung(15)|skin(1) 26 all_epithelial(167;2.95e-05)|all_lung(203;0.000396)|Lung NSC(277;0.00171) all cancers(265;0.0582)|Epithelial(280;0.0716)|Colorectal(170;0.0879)|KIRC - Kidney renal clear cell carcinoma(1967;0.202) CTGGGGGCACTGTGAAAGCAT 0.328000 3 101 0 0 0.150653 0 0 MROH7 374977 broad.mit.edu 37 1 55144970 55144970 + Missense_Mutation SNP A A G TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr1:55144970A>G ENST00000414150.2 + 12 2362 c.2084A>G c.(2083-2085)aAg>aGg p.K695R MROH7_ENST00000545244.1_Missense_Mutation_p.K263R|MROH7_ENST00000409996.1_Missense_Mutation_p.K263R|MROH7_ENST00000339553.5_Missense_Mutation_p.K695R|MROH7_ENST00000421030.2_Missense_Mutation_p.K695R|MROH7_ENST00000395690.2_Missense_Mutation_p.K695R|MROH7_ENST00000454855.2_Missense_Mutation_p.K213R maestro heat-like repeat family member 7 CAGCAGATAAAGGACCTGCTG 0.577000 4 138 0 0 0.150653 0 0 POLR3B 55703 broad.mit.edu 37 12 106820987 106820987 + Missense_Mutation SNP C C T TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr12:106820987C>T ENST00000228347.4 + 13 1336 c.1114C>T c.(1114-1116)Ctt>Ttt p.L372F POLR3B_ENST00000539066.1_Missense_Mutation_p.L314F|POLR3B_ENST00000549195.1_3'UTR NM_018082.5 NP_060552.4 Q9NW08 RPC2_HUMAN polymerase (RNA) III (DNA directed) polypeptide B 372 innate immune response|positive regulation of innate immune response|positive regulation of interferon-beta production|response to virus|termination of RNA polymerase III transcription|transcription elongation from RNA polymerase III promoter nucleoplasm DNA binding|DNA-directed RNA polymerase activity|metal ion binding|ribonucleoside binding p.L372F(2) breast(2)|central_nervous_system(1)|cervix(1)|endometrium(5)|kidney(3)|large_intestine(14)|lung(22)|ovary(1)|prostate(3)|skin(3)|urinary_tract(2) 57 TTTATCTCTTCTTTTTGAAGA 0.274000 4 16 0 0 0.150653 0 0 MYOF 26509 broad.mit.edu 37 10 95148810 95148810 + Missense_Mutation SNP A A G TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr10:95148810A>G ENST00000371501.4 - 18 1680 c.1558T>C c.(1558-1560)Tat>Cat p.Y520H MYOF_ENST00000371502.4_Missense_Mutation_p.Y520H|MYOF_ENST00000358334.5_Missense_Mutation_p.Y507H|MYOF_ENST00000359263.4_Missense_Mutation_p.Y520H Q9NZM1 MYOF_HUMAN myoferlin 520 blood circulation|muscle contraction|plasma membrane repair caveola|cytoplasmic vesicle membrane|integral to membrane|nuclear membrane phospholipid binding|protein binding NS(2)|autonomic_ganglia(1)|breast(3)|endometrium(7)|kidney(7)|large_intestine(15)|lung(14)|ovary(4)|prostate(4)|skin(6)|stomach(2)|upper_aerodigestive_tract(1)|urinary_tract(1) 67 AGCTCATCATAGGGGTCTGGG 0.408000 3 134 0 0 0.150653 0 0 CHRNA3 0 broad.mit.edu 37 15 78893607 78893607 + Silent SNP A A G TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr15:78893607A>G ENST00000326828.5 - 5 1761 c.1377T>C c.(1375-1377)aaT>aaC p.N459N CHRNA3_ENST00000348639.3_Silent_p.N459N NM_000743.4 NP_000734.2 P32297 ACHA3_HUMAN cholinergic receptor, nicotinic, alpha 3 (neuronal) 459 activation of transmembrane receptor protein tyrosine kinase activity|behavioral response to nicotine|locomotory behavior|regulation of acetylcholine secretion|regulation of dendrite morphogenesis|regulation of excitatory postsynaptic membrane potential|regulation of smooth muscle contraction|synaptic transmission involved in micturition|synaptic transmission, cholinergic cell junction|dendrite|neuronal cell body|nicotinic acetylcholine-gated receptor-channel complex|postsynaptic density|postsynaptic membrane acetylcholine receptor activity|nicotinic acetylcholine-activated cation-selective channel activity central_nervous_system(3)|cervix(1)|endometrium(3)|kidney(1)|large_intestine(1)|lung(5)|ovary(1)|prostate(1)|upper_aerodigestive_tract(1)|urinary_tract(1) 18 CTTTGGCTTCATTTTGTGCTT 0.408000 30 97 0 0 0.729181 0 0 PPP3R2 5535 broad.mit.edu 37 9 104357209 104357209 + Missense_Mutation SNP A A C TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr9:104357209A>C ENST00000374806.1 - 1 74 c.4T>G c.(4-6)Tcc>Gcc p.S2A GRIN3A_ENST00000361820.3_Intron NM_147180.2 NP_671709.1 Q96LZ3 CANB2_HUMAN protein phosphatase 3, regulatory subunit B, beta 0 calcium ion binding breast(1)|endometrium(2)|large_intestine(2)|lung(12)|ovary(1)|prostate(1)|skin(2)|upper_aerodigestive_tract(1) 22 Acute lymphoblastic leukemia(62;0.0527) Cyclosporine(DB00091) CCCATTGTGGACATCTGGCAA 0.607000 22 45 0 0 0.639603 0 0 RRN3P2 0 broad.mit.edu 37 16 29110458 29110458 + RNA SNP T T C rs151074589 by1000genomes TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr16:29110458T>C ENST00000564580.1 + 0 1131 p.W375R(25) GAATTTTGAGTGGATAGTGAT 0.328000 5 52 0 0 0.184627 0 0 DNAH8 1769 broad.mit.edu 37 6 38893891 38893891 + Missense_Mutation SNP A A T TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr6:38893891A>T ENST00000359357.3 + 72 10626 c.10372A>T c.(10372-10374)Att>Ttt p.I3458F RP1-207H1.3_ENST00000418399.1_RNA|DNAH8_ENST00000449981.2_Missense_Mutation_p.I3675F|DNAH8_ENST00000441566.1_Missense_Mutation_p.I3422F|RP1-207H1.3_ENST00000416948.1_RNA dynein, axonemal, heavy chain 8 NS(7)|breast(9)|central_nervous_system(4)|cervix(1)|endometrium(12)|haematopoietic_and_lymphoid_tissue(3)|kidney(16)|large_intestine(44)|liver(4)|lung(101)|ovary(7)|pancreas(2)|prostate(8)|skin(28)|stomach(4)|upper_aerodigestive_tract(6)|urinary_tract(4) 260 GAATGGCATTATTGTGACAAA 0.413000 16 115 0 0 0.520397 0 0 FAT3 120114 broad.mit.edu 37 11 92085432 92085432 + Missense_Mutation SNP G G A TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr11:92085432G>A ENST00000298047.6 + 1 171 c.154G>A c.(154-156)Gtg>Atg p.V52M FAT3_ENST00000541502.1_Missense_Mutation_p.V52M|FAT3_ENST00000409404.2_Missense_Mutation_p.V52M Q8TDW7 FAT3_HUMAN FAT atypical cadherin 3 52 Cadherin 1. homophilic cell adhesion|multicellular organismal development integral to membrane|plasma membrane calcium ion binding NS(1)|breast(2)|endometrium(10)|kidney(4)|large_intestine(11)|liver(2)|lung(37)|ovary(5)|pancreas(1)|prostate(4)|skin(2)|stomach(1)|upper_aerodigestive_tract(5) 85 Acute lymphoblastic leukemia(157;3.01e-05)|all_hematologic(158;0.00858) TAATGCTACCGTGTATGAGAA 0.488000 TCGA Ovarian(4;0.039) 5 35 0 0 0.184627 0 0 TBP 6908 broad.mit.edu 37 6 170871082 170871082 + Silent SNP G G A TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr6:170871082G>A ENST00000392092.2 + 3 537 c.258G>A c.(256-258)caG>caA p.Q86Q TBP_ENST00000540980.1_Silent_p.Q66Q|TBP_ENST00000230354.6_Silent_p.Q86Q NM_003194.4 NP_003185.1 P20226 TBP_HUMAN TATA box binding protein 86 Poly-Gln. cell death|interspecies interaction between organisms|transcription elongation from RNA polymerase II promoter|transcription from RNA polymerase III promoter|viral reproduction transcription factor TFIIA complex|transcription factor TFIID complex repressing transcription factor binding|transcription regulatory region DNA binding p.Q86Q(2) breast(2)|central_nervous_system(1)|endometrium(5)|kidney(1)|large_intestine(2)|lung(9)|ovary(1)|prostate(4)|urinary_tract(1) 26 Breast(66;5.08e-05)|Ovarian(120;0.125)|Esophageal squamous(34;0.246) OV - Ovarian serous cystadenocarcinoma(33;1.07e-22)|BRCA - Breast invasive adenocarcinoma(81;5.01e-06)|GBM - Glioblastoma multiforme(31;0.00591) agcagcagcagcagcagcagc 0.612000 4 13 0 0 0.150653 0 0 FMN1 342184 broad.mit.edu 37 15 33359620 33359620 + Missense_Mutation SNP C C T TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr15:33359620C>T ENST00000334528.9 - 1 465 c.466G>A c.(466-468)Gag>Aag p.E156K FMN1_ENST00000558197.1_Missense_Mutation_p.E156K|FMN1_ENST00000559047.1_Intron|FMN1_ENST00000561249.1_Intron|FMN1_ENST00000559150.1_Intron NM_001103184.2 NP_001096654.1 Q68DA7 FMN1_HUMAN formin 1 0 Microtubule-binding (By similarity). actin cytoskeleton organization actin cytoskeleton|adherens junction|cytoplasm|nucleus actin binding endometrium(3)|haematopoietic_and_lymphoid_tissue(2)|kidney(1)|large_intestine(3)|lung(14)|ovary(2)|prostate(1)|upper_aerodigestive_tract(3) 29 all_lung(180;1.14e-07) all cancers(64;3.05e-15)|Epithelial(43;1.67e-10)|GBM - Glioblastoma multiforme(186;4.95e-05)|BRCA - Breast invasive adenocarcinoma(123;0.0262) TCCTCTGGCTCCTGGCCACCA 0.517000 4 69 0 0 0.150653 0 0 NLGN2 57555 broad.mit.edu 37 17 7318155 7318155 + Missense_Mutation SNP C C T TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr17:7318155C>T ENST00000302926.2 + 4 905 c.832C>T c.(832-834)Cac>Tac p.H278Y NLGN2_ENST00000575301.1_Missense_Mutation_p.H278Y NM_020795.2 NP_065846.1 Q8NFZ4 NLGN2_HUMAN neuroligin 2 278 cell-cell junction maintenance|neuron cell-cell adhesion|positive regulation of synaptogenesis|regulation of inhibitory postsynaptic membrane potential|synapse assembly cell surface|integral to plasma membrane|postsynaptic membrane neurexin binding|receptor activity central_nervous_system(1)|endometrium(3)|kidney(3)|large_intestine(3)|lung(7)|prostate(2)|skin(3) 22 Prostate(122;0.157) GATCCTCTCCCACCATTCAGA 0.612000 13 43 0 0 0.411799 0 0 N6AMT1 29104 broad.mit.edu 37 21 30254531 30254531 + Missense_Mutation SNP T T C TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr21:30254531T>C ENST00000303775.5 - 3 288 c.263A>G c.(262-264)gAg>gGg p.E88G N6AMT1_ENST00000351429.3_Missense_Mutation_p.E88G NM_013240.4 NP_037372.3 Q9Y5N5 HEMK2_HUMAN N-6 adenine-specific DNA methyltransferase 1 (putative) 88 positive regulation of cell growth protein complex nucleic acid binding|protein binding|protein methyltransferase activity breast(1)|endometrium(1)|kidney(1)|large_intestine(1)|lung(6)|prostate(2) 12 GCGTGCTGTCTCTAGGGTACA 0.358000 19 51 0 0 0.608945 0 0 CCDC28B 79140 broad.mit.edu 37 1 32670247 32670248 + Frame_Shift_Del DEL TG TG - TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr1:32670247_32670248delTG ENST00000421922.2 + 5 674_675 c.574_575delTG c.(574-576)tfs p.C192fs CCDC28B_ENST00000373602.5_Intron|CCDC28B_ENST00000483009.1_Intron Q9BUN5 CC28B_HUMAN coiled-coil domain containing 28B 0 large_intestine(4)|lung(3)|ovary(1)|upper_aerodigestive_tract(2) 10 Myeloproliferative disorder(586;0.0255)|all_neural(195;0.0837)|Ovarian(437;0.101)|Breast(348;0.174) AACCCGTCTATGTGTGTGTGTT 0.500 8 273 --- --- --- --- SDHAP1 0 broad.mit.edu 37 3 195709193 195709193 + RNA DEL A A - TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr3:195709193delA ENST00000427841.1 - 0 750 NR_003264.2 TAAAAGAAAGAAAAAAAAAGG 0.423 2 4 --- --- --- --- ZNF23 7571 broad.mit.edu 37 16 71483441 71483444 + Frame_Shift_Del DEL AATT AATT - TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chr16:71483441_71483444delAATT ENST00000393539.2 - 6 1297_1300 c.484_487delAATT c.(484-489)ctfs p.NS162fs AC010547.9_ENST00000561908.1_3'UTR|RP11-510M2.10_ENST00000576258.1_RNA|ZNF23_ENST00000539742.1_5'UTR|ZNF23_ENST00000497160.1_3'UTR|ZNF23_ENST00000357254.4_Frame_Shift_Del_p.NS162fs|ZNF23_ENST00000428724.2_Frame_Shift_Del_p.NS104fs|ZNF23_ENST00000358700.2_3'UTR|ZNF23_ENST00000564528.1_Frame_Shift_Del_p.NS104fs|ZNF23_ENST00000417828.1_Frame_Shift_Del_p.NS162fs NM_145911.1 NP_666016.1 P17027 ZNF23_HUMAN zinc finger protein 23 162 regulation of transcription, DNA-dependent|transcription, DNA-dependent nucleus DNA binding|zinc ion binding NS(1)|central_nervous_system(2)|endometrium(2)|kidney(1)|large_intestine(7)|lung(14)|stomach(1)|urinary_tract(1) 29 Ovarian(137;0.00768) BRCA - Breast invasive adenocarcinoma(221;0.0686) CTTTCCTCAGAATTAATTATTTCA 0.402 10 109 --- --- --- --- ATRX 546 broad.mit.edu 37 X 76938777 76938777 + Frame_Shift_Del DEL T T - TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-10A-01D-1705-08 Untested Somatic Phase_I WXS none Illumina GAIIx 3189bd5c-ac35-4564-bbd1-744e17faf46d 71783be8-05e1-4cf5-9bf1-4f58ce54a273 g.chrX:76938777delT ENST00000373344.5 - 9 2185 c.1971delA c.(1969-1971)ccfs p.P657fs ATRX_ENST00000480283.1_5'UTR|ATRX_ENST00000395603.3_Frame_Shift_Del_p.P619fs NM_000489.3 NP_000480.2 P46100 ATRX_HUMAN alpha thalassemia/mental retardation syndrome X-linked 657 DNA methylation|DNA recombination|DNA repair|regulation of transcription, DNA-dependent nuclear heterochromatin ATP binding|chromo shadow domain binding|DNA binding|DNA helicase activity|zinc ion binding p.?(1) bone(1)|breast(6)|central_nervous_system(31)|cervix(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(15)|kidney(14)|large_intestine(1)|liver(1)|lung(40)|ovary(2)|pancreas(13)|prostate(5)|skin(2)|upper_aerodigestive_tract(3)|urinary_tract(2) 145 Phosphatidylserine(DB00144) TCTTTACACGTGGGGATCTTC 0.378 """Mis, F, N""" """Pancreatic neuroendocrine tumors, paediatric GBM""" ATR-X (alpha thalassemia/mental retardation) syndrome 147 43 --- --- --- ---